Kaye Biotech Inc. had the following equity account balances at December 31, 2019: $ 39,200 Preferred shares, $2.75, non-cumulative, Authorized: 21,200 shares Issued and outstanding: 5,600 shares Common shares, Authorized: Unlimited Issued and outstanding: 88,000 shares Retained earnings 297,849 43,000 On February 1, 2020,5,600 preferred shares were issued at $8.30 each. The board of directors declared and paid the annual cash dividend on the preferred shares on June 30, 2020, and a 15% common share dividend was declared and distributed on the same day when the market price per common share was $4.50. On October 1, 2020, 21,200 common shares were issued at $4.64 each. Profit earned during 2020 was $414,800. Required: Using the information provided, prepare the statement of changes in equity for the year ended December 31, 2020. (Amounts to be deducted should be indicated by a minus sign.) Retained Earnings Total Equity $ 0 KAYE BIOTECH INC. Statement of Changes in Equity For Year Ended December 31, 2020 Preferred Common Shares Shares Balance, January 1 Preferred shares issued Preferred cash dividends Common shares dividend Common shares issued Profit Balance, December 31 $ 0 $ 0 0 0 0 0 0 $ 0 $ 0